{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:47:26Z","timestamp":1789631246526,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004418","name":"VUB University","doi-asserted-by":"publisher","award":["SRP53"],"award-info":[{"award-number":["SRP53"]}],"id":[{"id":"10.13039\/501100004418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101179","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:59:39Z","timestamp":1777161579000},"page":"101179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring the role of hydrogen peroxide in the immune microenvironment of hypoxic tumors"],"prefix":"10.1016","volume":"59","author":[{"given":"Febe","family":"Geirnaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kerkhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6041-1042","authenticated-orcid":false,"given":"Tim","family":"Everaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4556-5681","authenticated-orcid":false,"given":"Thierry","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9945-4357","authenticated-orcid":false,"given":"In\u00e8s","family":"Dufait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4433-8807","authenticated-orcid":false,"given":"Mark De","family":"Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101179_b0005","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","article-title":"The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a factor in Radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2026.101179_b0010","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1093\/jrr\/rrw007","article-title":"The impact of hypoxia and its modification of the outcome of radiotherapy","volume":"57","author":"Horsman","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ctro.2026.101179_b0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ctro.2026.101179_b0020","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1158\/1078-0432.CCR-04-0436","article-title":"Phase I Study of Tirapazamine Plus Cisplatin\/Etoposide and concurrent Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer (S0004)","volume":"10","author":"Le","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctro.2026.101179_b0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0360-3016(89)90343-X","article-title":"A phase I\/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04)","volume":"16","author":"Lee","year":"1989","journal-title":"International Journal of Radiation Oncology*biology*physics"},{"key":"10.1016\/j.ctro.2026.101179_b0030","doi-asserted-by":"crossref","unstructured":"Ogawa. Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: A new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II). Int J Oncol 2009;34. https:\/\/doi.org\/10.3892\/ijo_00000186.","DOI":"10.3892\/ijo_00000186"},{"key":"10.1016\/j.ctro.2026.101179_b0035","first-page":"288","article-title":"Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. a prospective randomized trial with long-term follow-up","volume":"26","author":"Karatosun","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ctro.2026.101179_b0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/CIA.S2135","article-title":"Hyaluronic acid gel fillers in the management of facial aging","volume":"3","author":"Brandt","year":"2008","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.ctro.2026.101179_b0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3892\/ol.2016.5456","article-title":"Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane","volume":"13","author":"Aoyama","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ctro.2026.101179_b0050","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3390\/cancers7040891","article-title":"Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) using a New Radiosensitization Method (KORTUC II) for patients with stage I or II Breast Cancer","volume":"7","author":"Ogawa","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101179_b0055","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2011.1069","article-title":"Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral injection for low-LET radioresistant tumors","author":"Ogawa","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ctro.2026.101179_b0060","doi-asserted-by":"crossref","DOI":"10.3892\/or_00000968","volume":"24","author":"Miyatake","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ctro.2026.101179_b0065","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.3390\/cancers3033496","article-title":"Evaluation of changes in Tumor Shadows and Microcalcifications on Mammography following KORTUC II, a New Radiosensitization Treatment without any Surgical Procedure for elderly patients with stage I and II Breast Cancer","volume":"3","author":"Tsuzuki","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101179_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers8010001","volume":"8","author":"Yaogawa","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101179_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2025.15314","article-title":"Non\u2013surgical breast\u2013conserving treatment using Kochi oxydol\u2013radiation therapy for unresectable carcinomas II for patients with stage 0 to IIIC breast cancer","volume":"30","author":"Hori","year":"2025","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ctro.2026.101179_b0080","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2020.06.022","article-title":"Intratumoral Hydrogen Peroxide with Radiation Therapy in locally Advanced Breast Cancer: results from a phase 1 Clinical Trial","volume":"108","author":"Nimalasena","year":"2020","journal-title":"International Journal of Radiation Oncology*biology*physics"},{"key":"10.1016\/j.ctro.2026.101179_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110692","article-title":"Revisiting hydrogen peroxide as radiosensitizer for solid tumor cells","volume":"203","author":"Geirnaert","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101179_b0090","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s44276-024-00098-y","article-title":"Tumour reoxygenation after intratumoural hydrogen peroxide (KORTUC) injection: a novel approach to enhance radiosensitivity","volume":"2","author":"Nimalasena","year":"2024","journal-title":"BJC Reports"},{"key":"10.1016\/j.ctro.2026.101179_b0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/2326-6066.CIR-14-0196","article-title":"Stereotactic Radiation Therapy Augments Antigen-specific PD-1\u2013Mediated Antitumor Immune responses via Cross-Presentation of Tumor Antigen","volume":"3","author":"Sharabi","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ctro.2026.101179_b0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ctro.2026.101179_b0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","article-title":"Radiotherapy combined with immunotherapy: the dawn of cancer treatment","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ctro.2026.101179_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02916","article-title":"Previous Radiotherapy increases the Efficacy of IL-2 in Malignant Pleural Effusion: potential evidence of a Radio-memory effect?","volume":"9","author":"Chen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ctro.2026.101179_b0115","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101179_b0120","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.7150\/thno.86004","article-title":"In situ vaccination caused by diverse irradiation-driven cell death programs","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ctro.2026.101179_b0125","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"International Journal of Radiation Oncology*biology*physics"},{"key":"10.1016\/j.ctro.2026.101179_b0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/0007-1285-26-305-234","article-title":"Whole Body Irradiation\u2014Radiobiology or Medicine?","volume":"26","author":"Mole","year":"1953","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2026.101179_b0135","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-Year Survival Outcomes from the PACIFIC Trial: Durvalumab after Chemoradiotherapy in Stage III Non\u2013Small-Cell Lung Cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101179_b0140","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1111\/cas.15911","article-title":"Combination therapy with hydrogen peroxide and irradiation promotes an abscopal effect in mouse models","volume":"114","author":"Kemmotsu","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ctro.2026.101179_b0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/JLB.1MR1117-472R","article-title":"Metabolic regulation of leukocyte motility and migration","volume":"104","author":"Marelli-Berg","year":"2018","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ctro.2026.101179_b0150","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gad.1881410","article-title":"Differential activation and antagonistic function of HIF-\u03b1 isoforms in macrophages are essential for NO homeostasis","volume":"24","author":"Takeda","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.ctro.2026.101179_b0155","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/ATVBAHA.112.301008","article-title":"Hypoxia Induces Netrin-1 and Unc5b in Atherosclerotic Plaques","volume":"33","author":"Ramkhelawon","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ctro.2026.101179_b0160","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based Network Analysis reveals a Spectrum Model of Human Macrophage Activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ctro.2026.101179_b0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage Activation and Polarization: Nomenclature and Experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ctro.2026.101179_b0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40164-021-00252-z","article-title":"Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies","volume":"10","author":"Zhu","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.ctro.2026.101179_b0175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202170304","article-title":"Engineering Endogenous Tumor\u2010Associated Macrophage\u2010Targeted Biomimetic Nano\u2010RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo\u2010Immunotherapy","volume":"33","author":"Wang","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.ctro.2026.101179_b0180","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.3390\/ijms22136995","article-title":"Macrophage Polarization States in the Tumor Microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ctro.2026.101179_b0185","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3390\/cancers14061482","article-title":"Together Intra-Tumor Hypoxia and Macrophagic Immunity are Driven worst Outcome in Pediatric High-Grade Osteosarcomas","volume":"14","author":"Nazon","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2026.101179_b0190","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1093\/jimmun\/vkaf202","article-title":"Identification of novel protein biomarkers of macrophage polarization using comparative proteomic analyses of murine primary macrophages","volume":"214","author":"Liu","year":"2025","journal-title":"J Immunol"},{"key":"10.1016\/j.ctro.2026.101179_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100808","article-title":"The paradox of radiation and T cells in tumors","volume":"31","author":"Gough","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.ctro.2026.101179_b0200","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ijrobp.2004.05.065","article-title":"Macrophages enhance the radiosensitizing activity of lipid a: a novel role for immune cells in tumor cell radioresponse","volume":"60","author":"De Ridder","year":"2004","journal-title":"International Journal of Radiation Oncology*biology*physics"},{"key":"10.1016\/j.ctro.2026.101179_b0205","doi-asserted-by":"crossref","first-page":"16554","DOI":"10.1038\/s41598-020-73624-w","article-title":"M1 Macrophage and M1\/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer","volume":"10","author":"Oshi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctro.2026.101179_b0210","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1158\/0008-5472.CAN-20-0069","article-title":"Spatial Density and distribution of Tumor-Associated Macrophages Predict Survival in Non\u2013Small Cell Lung Carcinoma","volume":"80","author":"Zheng","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctro.2026.101179_b0215","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","article-title":"Metabolism of inflammation limited by AMPK and pseudo-starvation","volume":"493","author":"O\u2019Neill","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ctro.2026.101179_b0220","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1177\/15353702221080130","article-title":"Macrophage polarization in hypoxia and ischemia\/reperfusion: Insights into the role of energetic metabolism","volume":"247","author":"Yakupova","year":"2022","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.ctro.2026.101179_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080908","article-title":"Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages","volume":"8","author":"Barros","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ctro.2026.101179_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145342","article-title":"Novel Markers to Delineate Murine M1 and M2 Macrophages","volume":"10","author":"Jablonski","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ctro.2026.101179_b0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-08277-6","article-title":"Macrophages rescue cells from ferroptotic death","author":"Hefetz","year":"2025","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ctro.2026.101179_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103255","article-title":"Inhibition of ferroptosis rescues M2 macrophages and alleviates arthritis by suppressing the HMGB1\/TLR4\/STAT3 axis in M1 macrophages","volume":"75","author":"Feng","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.ctro.2026.101179_b0245","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41419-022-04775-z","article-title":"Interaction between macrophages and ferroptosis","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ctro.2026.101179_b0250","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202203973","article-title":"Targeted xCT\u2010mediated Ferroptosis and Protumoral Polarization of Macrophages is Effective against HCC and Enhances the Efficacy of the Anti\u2010PD\u20101\/L1 Response","volume":"10","author":"Tang","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.ctro.2026.101179_b0255","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301561","article-title":"A Dihydroartemisinin\u2010Loaded Nanoreactor Motivates Anti\u2010Cancer Immunotherapy by Synergy\u2010Induced Ferroptosis to Activate Cgas\/STING for Reprogramming of Macrophage","volume":"12","author":"Li","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ctro.2026.101179_b0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ctro.2026.101179_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102463","article-title":"Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing","volume":"56","author":"Hao","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.ctro.2026.101179_b0270","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.2147\/IJN.S440405","article-title":"Synergistically Enhancing Immunotherapy Efficacy in Glioblastoma with Gold-Core Silica-Shell Nanoparticles and Radiation","volume":"18","author":"Chen","year":"2023","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.ctro.2026.101179_b0275","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1186\/s12951-024-02999-z","article-title":"Zinc-based radioenhancers to activate tumor radioimmunotherapy by PD-L1 and cGAS-STING pathway","volume":"22","author":"Xu","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.ctro.2026.101179_b0280","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005011","article-title":"Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control","volume":"11","author":"Rodriguez-Ruiz","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ctro.2026.101179_b0285","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/acsbiomaterials.5b00181","article-title":"High and Low Molecular Weight Hyaluronic Acid Differentially Influence Macrophage Activation","volume":"1","author":"Rayahin","year":"2015","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.ctro.2026.101179_b0290","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/acsnano.5b06779","article-title":"Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia","volume":"10","author":"Song","year":"2016","journal-title":"ACS Nano"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:48:32Z","timestamp":1783396112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":58,"alternative-id":["S2405630826000741"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101179","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of hydrogen peroxide in the immune microenvironment of hypoxic tumors","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101179"}}